Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van Poppel

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|January 8, 2004
Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancerW Albrecht, H Van Poppel, S Horenblas, et al.
International Journal of Cancer|September 27, 2000
Selective activation of the fatty acid synthesis pathway in human prostate cancerJ V Swinnen, F Vanderhoydonc, A A Elgamal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1992
Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissueP Dal Cin, M S Aly, J Delabie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancerC N Sternberg, H Dumez, H Van Poppel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1997
Age is not a limiting factor for radical radiotherapy in pelvic malignanciesT Pignon, J C Horiot, M Bolla, et al.
International Journal of Cancer|April 10, 1997
Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinomaL E Van den Hove, S W Van Gool, H Van Poppel, et al.
American Journal of Clinical Oncology|April 1, 1997
Adenocarcinoma of the prostate: innovations in managementZ Petrovich, L Baert, M A Bagshaw, et al.
Actas Urologicas Espanolas|October 5, 2020
Telemedicine and smart working: Spanish adaptation of the European Association of Urology recommendationsJ Gómez Rivas, A Rodríguez-Serrano, S Loeb, et al.
British Journal of Cancer|November 8, 2012
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesB Beuselinck, P Wolter, A Karadimou, et al.
British Journal of Cancer|May 17, 2007
High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profileM M Baldewijns, V L Thijssen, G G Van den Eynden, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|January 8, 2004
Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancerW Albrecht, H Van Poppel, S Horenblas, et al.
International Journal of Cancer|September 27, 2000
Selective activation of the fatty acid synthesis pathway in human prostate cancerJ V Swinnen, F Vanderhoydonc, A A Elgamal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1992
Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissueP Dal Cin, M S Aly, J Delabie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancerC N Sternberg, H Dumez, H Van Poppel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1997
Age is not a limiting factor for radical radiotherapy in pelvic malignanciesT Pignon, J C Horiot, M Bolla, et al.
International Journal of Cancer|April 10, 1997
Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinomaL E Van den Hove, S W Van Gool, H Van Poppel, et al.
American Journal of Clinical Oncology|April 1, 1997
Adenocarcinoma of the prostate: innovations in managementZ Petrovich, L Baert, M A Bagshaw, et al.
Actas Urologicas Espanolas|October 5, 2020
Telemedicine and smart working: Spanish adaptation of the European Association of Urology recommendationsJ Gómez Rivas, A Rodríguez-Serrano, S Loeb, et al.
British Journal of Cancer|November 8, 2012
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastasesB Beuselinck, P Wolter, A Karadimou, et al.
British Journal of Cancer|May 17, 2007
High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profileM M Baldewijns, V L Thijssen, G G Van den Eynden, et al.
Pageof 21